Together, high levels of NRF2 expression in GC lead to the production of antioxidants, which would enable these tumor cells to resist reactive oxygen species and gain higher malignant properties.20 These indicate that NRF2 expression levels may be used as a predictor of prognosis in patients with GC. The gene discussed is NFE2L2; the disease is neoplasm.